Successful Treatment of Psoriasis and Psoriatic Arthritis with Etanercept and Methotrexate in a Patient Newly Unresponsive to Infliximab [6]

Archives of Dermatology

Volumn 140, Issue 3, 2004, Pages 366-

  Strober, Bruce E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIBODY; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

ADULT; ANTIBODY RESPONSE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; JOINT STIFFNESS; LETTER; LOW BACK PAIN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SYMPTOM;

ADMINISTRATION, ORAL; ADULT; ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT FAILURE;

EID: 12144291226     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.3.366     Document Type: Letter

References (5)

1. Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trial. Lancet. 2001;357:1842-1847.
2. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet. 2000;356:385-390.
3. Ogilvie AL, Antoni C, Dechant C, et al. Treatment of psoriatic arthritis with antitumor necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate. Br J Dermatol. 2001;144:587-589.
4. Cohen RD, Tsang JF, Hanauer SB. Infliximab in Crohn's disease: first anniversary clinical experience. Am J Gastroenterol. 2000;95:3469-3477.
5. Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998;41:1552-1563.